Sun Pharma Shares Crash as SEBI Plans to Reopen Insider Trading Case in Top Business News- News18.com published on December 02, 2018 leave a reply Sun Pharmaceutical, its managing director Dilip Shanghvi and nine othes settled an insider trading probe on payment of Rs 18 lakh towards settlement charges. from Top Business News- News18.com https://ift.tt/2EaLLVQ Tweet Share Share Share Share Previous Post Moody's Expects Real GDP to Grow 7.2%, Outlook on Indian Banks Stable Next Post Sensex Surges Over 200 Points on US-China Trade Truce post written by: Rohit Related PostsUK Economy Grows By Monthly 1.1% In September, Slower Than ExpectedBritain's economy, which has struggled to maintain its recovery from its coronavirus lockdown crash, grew by a slower than expected 1.1% in September from Augus… Continue ReadingUK Economy Loses More Speed In September, Before New LockdownBritain's economy, which has struggled to maintain its recovery from its coronavirus lockdown crash, grew by a slower than expected 1.1% in September from Augus… Continue ReadingEmirates Posts $3.4 Billion Half-year Loss As COVID-19 Hits FlightsEmirates lost $3.4 billion in the first six months of the year, tipping the Dubai stateowned airline's holding company into its first halfyear loss in more than… Continue ReadingNissan Cuts Annual Operating Loss Estimate To 340 Billion YenNissan Motor Co Ltd revised its fullyear forecast to an operating loss of 340 billion yen ($3.23 billion) from a previous prediction for a record 470 billion ye… Continue ReadingWorld Shares Slip On Doubts Over COVID Vaccines, OutbreaksWorld stocks fell back on Thursday after an overnight comeback by big technology shares that have thrived during the pandemic. from Top Business News- News18.c… Continue Reading
0 comments: